Zostavax Vaccine to prevent Shingles May Cause Serious Injuries
Merck & Co. Inc.’s shingles vaccine, Zostavax, allegedly causes blindness, facial paralysis, encephalitis, meningitis, loss of dexterity, liver failure and even death in some cases.
Pharmaceutical giant, Merck & Co. Inc. makes the Zostavax vaccine which was approved by the U.S. Food and Drug Administration in 2006 for the prevention of shingles.
Zostavax differs from other vaccines in that it contains a live, but weakened form of the herpes zoster virus intended to activate the immune system. After fighting the weakened version of the virus, the body builds immunity. To prevent shingles, a viral infection, the shingles vaccine is prescribed.
Zostavax Allegedly May Cause the Development of Shingles
- Shingles can cause painful blistering rash characterized on one side of the torso and/or face especially to immunocompromised patients including elderly or senior age patients or those undergoing cancer treatments or with weakened immune systems.
- Some patients may have contracted the virus from the live shingles vaccine and have experienced serious post shingles-related injuries including post-herpetic neuralgia, retinal necrosis, keratitis and acute myelitis.
Failure To Warn Of Potential Dangerous Side Effects
The manufacturer, Merck & Co., Inc. allegedly knew about the vaccine’s dangerous side effects but failed to warn about the potential serious side effects of the Zostavax shingles vaccine.